TFFP - TFF Pharmaceuticals expands R&D operations with new Austin facility

• TFF Pharmaceuticals ( NASDAQ: TFFP ) has announced a significant expansion of its R&D operations through the lease of a new research and development facility located in Austin, Texas.
• As TFF expands its in-house and partnered research, including applications in biologics, the additional laboratory space will also provide significantly more real estate to accommodate larger equipment to facilitate scale-up and manufacturing.
• The Co. also plans to expand the product development team in Austin, which will be based at the new facility, to support the growing number of partnered projects.
• “As our internal programs advance and our network of partnerships expands, establishing this additional research space in Austin is a natural next step,” added Glenn Mattes, CEO of TFF Pharmaceuticals.

For further details see: